Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study
Risankizumab promotes a progressive anti-inflammatory effect, more prominent in patients with a faster response in the early phases of treatment.
Authors
- Susanna Rossari
- Nicola Pimpinelli (ORCID: https://orcid.org/0000-0003-1001-7810)
- Salvatore Panduri (ORCID: https://orcid.org/0000-0003-1383-498X)
- Michela Magnano (ORCID: https://orcid.org/0000-0001-9429-9004)
- E Lorenzoni
- Emanuele Trovato (ORCID: https://orcid.org/0000-0001-8301-9206)
- Martina Dragotto (ORCID: https://orcid.org/0009-0006-9441-3923)
- Eugenio Capalbo (ORCID: https://orcid.org/0009-0006-1693-4539)
- Federica Ricceri (ORCID: https://orcid.org/0000-0003-1883-4268)
- Leonardo Pescitelli (ORCID: https://orcid.org/0000-0002-5687-5485)
- Elia Rosi (ORCID: https://orcid.org/0000-0002-4227-7847)
- Antonella Di Cesare (ORCID: https://orcid.org/0000-0002-1001-4604)
- Alessandra Michelucci (ORCID: https://orcid.org/0000-0002-0795-0338)
- Flavia Manzo Margiotta (ORCID: https://orcid.org/0000-0002-9593-9357)
- Pietro Rubegni (ORCID: https://orcid.org/0000-0002-7762-9312)
- Marco Romanelli (ORCID: https://orcid.org/0000-0002-4127-0141)
- Gionata Buggiani
- Francesca Prignano (ORCID: https://orcid.org/0000-0002-5997-2045)
- Nicola Milanesi (ORCID: https://orcid.org/0000-0003-1055-3867)
- Imma Savarese
Institutions
- University of Siena (IT)
- University of Pisa (IT)
- IMT School for Advanced Studies Lucca (IT)
- Ospedale San Donato (IT)
- Ospedale San Giuseppe (IT)
- Ospedale Versilia (IT)
- University of Florence (IT)
Publication Details
- Journal
- Dermatology Practical & Conceptual
- Published
- 2025-10-31
- DOI
- https://doi.org/10.5826/dpc.1504a5733
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00